招商证券股份有限公司 关于湖南新五丰股份有限公司 发行股份及支付现金购买资产并募集配套资金暨关联交易 之限售股份上市流通的核查意见 招商证券股份有限公司（以下简称"招商证券"、"独立财务顾问"）作 为湖南新五丰股份有限公司（以下简称"新五丰"、"上市公司"、"公司"） 2022 年发行股份及支付现金购买资产并募集配套资金项目（以下简称"本次重 组"、"本次交易"）的持续督导独立财务顾问，根据《上市公司重大资产重 组管理办法（2025 修正）》《上市公司并购重组财务顾问业务管理办法》《上 海证券交易所股票上市规则（2025 年 4 月修订）》和《上海证券交易所上市公 司自律监管指引第 1 号——规范运作（2025 年 5 月修订）》等相关法律法规及 规范性文件的规定，对公司本次重组部分限售股解除限售并上市流通事项进行 了审慎核查，具体情况如下： 一、本次申请解除限售股份的基本情况 （一）本次限售股上市类型 新五丰本次限售股上市流通类型为发行股份及支付现金购买资产向特定对 象发行限售股。 （二）本次限售股核准情况 中国证券监督管理委员会于 2022 年 12 月 28 日出具《关于核准湖南新五丰 股份有限公司向湖 ...

证券代码：600975 证券简称：新五丰 公告编号：2025-062 湖南新五丰股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨 关联交易之限售股股票上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 湖南新五丰股份有限公司（以下简称"新五丰"或"公司"）本次限售股上市 流通类型为发行股份及支付现金购买资产向特定对象发行限售股。具体情况如下： （一）股票发行核准情况 重要内容提示： 本次股票上市类型为非公开发行股份；股票认购方式为网下，上市股数为 232,705,626股。 本次股票上市流通总数为232,705,626股。 本次股票上市流通日期为2026 年 1 月 6 日。 一、本次限售股上市类型 2022 年 12 月 29 日，公司收到中国证券监督管理委员会核发的《关于核准湖 南新五丰股份有限公司向湖南省现代农业产业控股集团有限公司等发行股份购买 资产并募集配套资金的批复》（证监许可[2022]3238 号），核准公司发行股份购买相 关资产，并核准公司发行股份募集配套资金不超过 17.70 亿元 ...

每经AI快讯，新五丰（SH 600975，收盘价：5.85元）12月25日晚间发布公告称，公司限售股份约2.33 亿股将于2026年1月6日解禁并上市流通，占公司总股本比例为18.62%。 每经头条（nbdtoutiao）——对话马斯克脑机接口"一号受试者"：大脑植入芯片23个月，我正重新夺回 人生的独立 （记者 王晓波） 2024年1至12月份，新五丰的营业收入构成为：畜牧业占比76.4%，批发和零售占比22.81%，饲料加工 占比0.69%，其他业务占比0.1%。 截至发稿，新五丰市值为73亿元。 ...

创新驱动"增长极"：模式革新与产业链协同，激活发展动能 在筑牢养殖根基的同时，新五丰积极探索创新路径，通过模式革新激发员工活力，依托产业链协同释放 发展势能，为企业高质量发展注入新动力。 创新推行的"模拟代养"模式，让员工从"打工者"转变为"经营者"。鼓励员工经营管理基地后，大家更主 动关注成本控制、生产效率与猪只健康，在实现个人收入提升的同时，也推动了企业效益增长，实现个 人与企业的双赢。 长沙晚报全媒体记者 曹开阳 周期性变化历来就是生猪产业必须破解的难题。2025年，湖南新五丰股份有限公司（以下简称"新五 丰"）及其旗下子公司迎难而上，从养殖端的精耕细作到模式上的创新突破，再到全链条的成本管控， 以一系列提质增效的"组合拳"，书写生猪产业发展的新篇章。 深耕养殖"基本盘"：双轮驱动，筑牢产业根基 母猪是生猪养殖的"核心芯片"，仔猪则是未来利润的"希望种子"。2025年以来，新五丰将提升母猪生产 效率与优化仔猪成本作为重中之重，通过科学管理与技术赋能，实现了养殖端的质效双升。 在母猪效率提升方面，新五丰多管齐下挖掘生产潜力：通过科学淘汰老龄低产母猪、引入健康高产后备 母猪，优化胎龄结构打造活力母猪群；广东 ...

Group 1 - The establishment of Jucheng Xincai (Beijing) Enterprise Management Partnership (Limited Partnership) with a registered capital of 2.375 billion yuan [1] - The business scope includes enterprise management and enterprise management consulting [1] - The company is jointly held indirectly by China Chengtong Holdings Group Co., Ltd. and China National Building Material Group Corporation [1]

"死磕降本是生猪养殖企业的当务之急。"这已成为2025年生猪养殖企业的生存共识。 新五丰是国内较早的生猪规模化养殖实践者，一直将生猪养殖作为公司重点发展的核心业务。近年 来，公司以生猪养殖为基础，通过机制创新，提质增效，降低成本，正在探索生猪养殖高质量发展之 路。 降低成本，提升生猪生产成本竞争力 面对猪价跌跌不休、产能去化远水难解近渴，猪企的当务之急还是死磕降本。 "今年3月开始，随着玉米价格的上涨，我们饲料用料由玉米切换到小麦，每吨饲料节约了50元左 右，通过饲料配方的切换，饲料成本优化空间达到了5%，上半年光饲料成本节约了2700万元。"新五丰 分管饲料板块的周庆华副总经理说。 目前，新五丰的饲料板块的技术团队，从营养技术提高、本地资源替代蛋白饲料、分阶段精细管理 营养等多方面降低饲料成本，不断提升公司行业竞争力。 衡南晟峰母猪场是新五峰的母猪标杆场，位于衡南县花桥镇，母猪设计规模1.2万头。衡南晟峰的 场长赵菊文说，控制成本是我们猪场的重要工作之一，精准控制喂料成本、强化内部考核遏制浪费行 为、培养饲养人员责任心等多方面都在降低成本。 "针对这个生长阶段仔猪的营养需求，要采用少食多餐的方式喂养，减少饲 ...

Group 1 - The establishment of Nengcheng Juliyi (Tianjin) Enterprise Management Partnership (Limited Partnership) with a registered capital of 3.125 billion yuan [1] - The business scope includes enterprise management and enterprise management consulting [1] - The company is jointly funded by Beijing Chengtong Capital Investment Co., Ltd., a wholly-owned subsidiary of China Chengtong Holdings Group Co., Ltd., and China Energy Engineering Group Co., Ltd. along with its subsidiary, China Energy Construction Fund Management Co., Ltd. [1]

Group 1: Market Performance - The aquaculture sector increased by 0.87% on December 15, with Luo Niushan leading the gains [1] - The Shanghai Composite Index closed at 3867.92, down 0.55%, while the Shenzhen Component Index closed at 13112.09, down 1.1% [1] Group 2: Individual Stock Performance - Luo Niushan (000735) closed at 11.17, up 6.99%, with a trading volume of 2.5612 million shares and a transaction value of 2.79 billion [1] - Zhengbang Technology (002157) closed at 3.73, up 4.48%, with a trading volume of 6.8748 million shares and a transaction value of 2.59 billion [1] - Other notable stocks include Juxing Agriculture (603477) at 17.69, up 2.25%, and Shennong Group (605296) at 28.22, up 1.88% [1] Group 3: Capital Flow Analysis - The aquaculture sector saw a net inflow of 11.2465 million from institutional investors, while retail investors experienced a net outflow of 13.7316 million [2] - Main stocks with significant net inflows include Luo Niushan with 42.7010 million and Wen's Shares (300498) with 21.6029 million [3] - Retail investors showed a negative trend in several stocks, including Juxing Agriculture and New Hope, indicating a shift in investor sentiment [3]

证券代码：600975 证券简称：新五丰 公告编号：2025-061 湖南新五丰股份有限公司 2025年11月生猪业务主要经营数据公告 登录新浪财经APP 搜索【信披】查看更多考评等级 二、特别说明与风险提示 1、上述数据均未经审计，与定期报告披露的数据之间可能存在差异，上述数据仅作为阶段性数据，供 投资者参考。因四舍五入，以上数据可能存在尾差。 2、基于动物疫情对生猪行业的影响持续存在、生猪市场价格波动较大以及公司养殖节奏变化等因素影 响，未来公司生猪销量存在月度波动风险。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 湖南新五丰股份有限公司（以下简称"公司"或"本公司"）现将2025年11月主要经营数据公告如下： 一、主要经营数据 （一）生猪销售情况 1、2025年11月公司生猪销售情况 ■ 2、2025年11月，公司销售生猪数量57.55万头，其中：销售商品猪33.83万头。 ■■ 3、生猪市场价格变动的风险是整个生猪生产行业的系统风险，对任何一家生猪生产者来讲都是客观存 在的、不可控制的外部风险。 三、其他提示 本公 ...

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]